Results 231 to 240 of about 6,812,052 (298)

Triadic capabilities of sales personnel in power generation enterprises under China's electricity market reform: Generation and evolution mechanisms. [PDF]

PLoS One
Kong Q, Lin P, Gu T.
europepmc   +1 more source

Targeting the EpCAM‐AXL axis to overcome drug resistance in lung cancer

Molecular Oncology, EarlyView.
Lung cancer cells often evade therapy by hijacking signaling pathways. We reveal that cleaved EpCAM (sEpCAM) stabilizes the oncogenic protein AXL, driving NF‐κB and STAT3‐mediated chemoresistance. This EpCAM‐AXL axis identifies a high‐risk patient subset with poor prognosis.
Alexa Guerrero‐Alba, Mark Shacker, Timothy P. Fleming, Michael A. Smith, Ross M. Bremner, Narendra V. Sankpal   +5 more
wiley   +1 more source

Enantiomer-Specific Nucleation Phase Selection under Nonequilibrium Optical Trapping. [PDF]

J Phys Chem Lett
Wang WC, Zhang QY, Okano K, Yoshikawa HY, Sugiyama T.   +4 more
europepmc   +1 more source

Characterization of therapeutic antibodies targeting lymphatic and vascular resistance factor for the treatment of hypervascularized and highly metastatic cancers

Molecular Oncology, EarlyView.
LVRF (lymphatic and vascular resistance factor) is a VEGFA splice variant upregulated in response to anti‐angiogenic therapy that fosters tumor adaptation through enhanced vascularization, lymphangiogenesis, and metastatic dissemination. Targeting LVRF with fully human neutralizing antibodies disrupts these processes and limits resistant tumor growth ...
Marion David, Arthur Karaulic, Audrey Bennetot, Clémence Fournier, Quentin Odet, Arthur Gouraud, Isabelle Bourget, Cédric Gaggioli, Sandy Giuliano, Frédéric Luciano, Olivier Léger, Zaki Sellam, Gilles Pagès   +12 more
wiley   +1 more source

Peptide Terminated Polymer Brush Nanomaterials for Label-Free Separation of Cancer Cells Based on Relative Adhesion. [PDF]

Small
Horan S, Wdowicz A, Feely N, Li P, Tagit O, Wang W, Lee GU.   +6 more
europepmc   +1 more source

Reprogramming tumor cells with LCOR mRNA nanotherapy to enhance immunotherapy

Molecular Oncology, EarlyView.
LCOR (Ligand‐dependent corepressor) mRNA encapsulated in polymeric nanoparticles restores LCOR activity in tumor cells, constraining aggressive tumor cell states and increasing tumor immunogenicity. This reprogramming makes tumor cells more vulnerable to T‐cell attack and enhances their response to immune‐checkpoint immunotherapy.
Gabriel Serra‐Mir, Elena Haro‐Martínez, Sandra Blasco‐Benito, Chiara Cannatà, José Ángel Palomeque, Anna López‐Plana, Maria Sanz‐Flores, Marc Sabartés, Cristina Fornaguera, Toni Celià‐Terrassa   +9 more
wiley   +1 more source

High-Intensity Focused Ultrasound as a Therapeutic Option to Treat Biostimulator's Nodules: A Case Report. [PDF]

J Cosmet Dermatol
Vilar AN, Azulay V, Vargas E, Azulay RD, Boson LL, Mesquita LF, Cordeiro A.   +6 more
europepmc   +1 more source

Antibacterial and Immunomodulatory Activities of a Natural Polysaccharide Against <i>Staphylococcus aureus</i> Infection. [PDF]

Food Sci Nutr
Xia XC, Peng YQ, Liu LX, Cao B, Zhong XK, Wu XD, Liu T.   +6 more
europepmc   +1 more source

Hybrid 1D CNN-BiLSTM with focal loss for robust intrusion detection in in-vehicle CAN networks. [PDF]

PLoS One
Malini A, Mary GI.
europepmc   +1 more source